Experienced in Pure Red Cell Aplasia

Dr. David A. Williams

Pediatric Hematology Oncology
300 Longwood Ave, Karp 8, 
Boston, MA 
Experienced in Pure Red Cell Aplasia
300 Longwood Ave, Karp 8, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Williams is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Williams is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. His top areas of expertise are X-Linked Severe Combined Immunodeficiency, Anemia, Sickle Cell Disease, Adrenoleukodystrophy (ALD), and Bone Marrow Transplant.

His clinical research consists of co-authoring 182 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pure Red Cell Aplasia.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in MA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

300 Longwood Ave, Karp 8, Boston, MA 02115

Additional Areas of Focus

Dr. Williams has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug, Procedure, Radiation
Study Phase: Not Applicable
A Two-Part, Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
A Two-Part, Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Enrollment Status: Completed
Publish Date: May 02, 2025
Intervention Type: Biological
Study Drug: Lentiviral G1XCGD Gene Therapy
Study Phase: Phase 1/Phase 2
Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Genetic
A Phase 1/2, Open-label, Single-arm Study to Assess the Safety, Tolerability, and Efficacy of ST-400 Autologous Hematopoietic Stem Cell Transplant for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)
A Phase 1/2, Open-label, Single-arm Study to Assess the Safety, Tolerability, and Efficacy of ST-400 Autologous Hematopoietic Stem Cell Transplant for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)
Enrollment Status: Completed
Publish Date: December 14, 2023
Intervention Type: Genetic
Study Drug: BCL11A-Positive CD34-Positive Hematopoietic Stem Cells
Study Phase: Phase 1/Phase 2
Serum Ferritin as a Predictor for Development of Anemia in Pregnancy: A Pilot Study
Serum Ferritin as a Predictor for Development of Anemia in Pregnancy: A Pilot Study
Enrollment Status: Unknown
Publish Date: December 03, 2019
View 4 Less Clinical Trials

182 Total Publications

Regression of Monosomy 7 Clone in Patient With RECQL4-Associated Syndrome.
Regression of Monosomy 7 Clone in Patient With RECQL4-Associated Syndrome.
Journal: American journal of hematology
Published: March 13, 2025
Similar Doctors
Distinguished in Pure Red Cell Aplasia
Dr. Vijay G. Sankaran
Pediatric Hematology Oncology
Distinguished in Pure Red Cell Aplasia
Dr. Vijay G. Sankaran
Pediatric Hematology Oncology
450 Brookline Avenue, Dana-farber Cancer Institute, 
Boston, MA 
 (0.1 miles away)
617-355-6363
Languages Spoken:
English
See accepted insurances

Vijay Sankaran is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Sankaran is rated as a Distinguished provider by MediFind in the treatment of Pure Red Cell Aplasia. His top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Anemia, Splenectomy, and Microvascular Decompression.

Distinguished in Pure Red Cell Aplasia
Dr. Colin A. Sieff
Pediatric Hematology Oncology
Distinguished in Pure Red Cell Aplasia
Dr. Colin A. Sieff
Pediatric Hematology Oncology
300 Longwood Ave, Fegan 7, 
Boston, MA 
 (0.1 miles away)
617-258-5228
Languages Spoken:
English
See accepted insurances

Colin Sieff is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Sieff is rated as a Distinguished provider by MediFind in the treatment of Pure Red Cell Aplasia. His top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Aplastic Anemia, and Transient Erythroblastopenia of Childhood.

Distinguished in Pure Red Cell Aplasia
Dr. Akiko Shimamura
Pediatric Hematology Oncology
Distinguished in Pure Red Cell Aplasia
Dr. Akiko Shimamura
Pediatric Hematology Oncology
300 Longwood Ave, 
Boston, MA 
 (0.1 miles away)
617-919-2508
Languages Spoken:
English
See accepted insurances

Akiko Shimamura is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Shimamura is rated as an Elite provider by MediFind in the treatment of Pure Red Cell Aplasia. Her top areas of expertise are Shwachman-Diamond Syndrome, Aplastic Anemia, Aase Syndrome, Familial Multiple Lipomatosis, and Bone Marrow Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Williams's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 10 Advanced Conditions
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile